Skip to main content

Article Published on 5.12.2022, 13:16

Insights accelerated access to sleep apnea studies and receiving the results

Keywords:
  • sleep apnea
  • medical research
  • HUS Diagnostic Center

Polysomnography is used to investigate respiratory disturbances during sleep when sleep apnea is suspected or the causes of daytime insomnia are investigated. Polysomnography uses a device that is put on at home before going to bed.

Lääkärimies ja potilas selin.

The number of patients who underwent a polysomnography multiplied: in 2017, a total of 1,751 patients were studied, and in 2022, the polysomnography was conducted on more than 6,000 patients. Although the number of patients increased, the total time physicians spent on all polysomnographies was reduced by 52% and nurses’ working hours were reduced by 15% already during the first year of the project.

In 2017, the polysomnography equipment was retrieved from the clinical neurophysiology unit in advance, and the device guidance given to the patient in person took half an hour. Nurses instructed 4–5 patients per day. The content of the guidance with different patients was often the same.

Then the number of referrals made to HUS to investigate sleep apnea increased dramatically.

Access to guidance, providing statements and making a diagnosis were achieved significantly more quickly with suspected sleep apnea

Clinical neurophysiology in HUS Diagnostic Center was able to accelerate the process with an insight that one could provide guidance to more than one patient at a time, and group guidance sessions were started alongside individual guidance. The provision of reports and statements was accelerated by streamlining report content into three categories. This allowed the physician’s reporting to be carried out almost three times as fast.

Polysomnography can be selected with individual or group guidance

Patients receive a referral for polysomnography from primary healthcare, allowing them to quickly book an appointment online to receive individual or group guidance in their preferred unit, as they choose. Individual guidance is still recommended if the patient requires an escort or if assistance is needed in setting up the equipment to be worn.

There are up to five patients in the groups depending on the pandemic situation. First, the nurse will shows how to put on the device. Patients repeat the same, each with their own device. After the guidance, there is time reserved for questions and personal advice.

Effectiveness of the project: Significantly more polysomnographies have been performed, the physicians and nurses have saved working hours, and the patient has received their report on the examination faster

  • The number of patients who completed the polysomnography multiplied: in 2017, a total of 1,751 patients were studied, and in 2022, the polysomnography was conducted on more than 6,000 patients.
  • Although the number of studies completed has multiplied, the report is received quickly, i.e., on average less than a week after the study.
  • Although the number of patients increased, the total time physicians spent on all polysomnographies was reduced by 52% and nurses’ working hours were reduced by 15% already during the first year of the project.
  • Situation now: access to polysomnography varies so that sometimes the study can be conducted as soon as within a week or the patient may need to wait for as long as two months, but before group guidance sessions were arranged, the waiting lists were considerably longer.

Several projects on effectiveness are ongoing at the HUS Diagnostic Center

The Diagnostic Center is the second largest profit area in HUS and employs more than 3,000 laboratory and imaging experts. The Diagnostic Center consists of three departments: radiology and pathology; physiology, genetics and preanalytics; and chemistry and microbiology.

There are several effectiveness projects ongoing at the HUS Diagnostic Center, the goal of which is to make the studies performed on patients as effective as possible. HUS wants its patients to receive even more health benefits whenever they interact with HUS.

Development projects are led by the Chief of Clinical Neurophysiology, Head of Division Erika Haaksiluoto .

Feedback

Did you find what you were looking for?

Thank you for your feedback!

Thank you for your feedback!

Write your feedback on the website here.

Do not enter your personal information here. Please note that we do not respond to feedback sent via this form. Please visit our feedback site to give feedback on matters other than our website.

Write your feedback on the website here.

Do not enter your personal information here. Please note that we do not respond to feedback sent via this form. Please visit our feedback site to give feedback on matters other than our website.